SOFTMEDX (00648) announced its final results for the period ending 2025. The group recorded revenue of HK$68.243 million, representing an increase of 24.9% compared to the previous year. However, the annual profit was HK$6.95 million, a sharp decrease of 97.87% year-on-year. The basic earnings per share stood at HK$0.012.